BMS-593214 is a site-directed inhibitor of coagulation factor VIIa (FVIIa) with antithrombotic and antihemorrhagic properties; it acts as a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of FVIIa-mediated activation of substrate FX; it prevents electrically induced carotid artery thrombosis (AT) and thread-induced inferior vena cava thrombosis (VT).